Literature DB >> 20146368

Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.

C Keen1, P Gustafsson, A Lindblad, G Wennergren, A-C Olin.   

Abstract

Fraction of exhaled nitric oxide (FENO) is often reduced in cystic fibrosis (CF). FENO at different expiratory flows can provide an indication of the site of nitric oxide production. The aim of this study was to examine whether NO parameters are related to overall (FEV(1)) or peripheral (lung clearance index, LCI, measured by multiple breath SF(6) washout) airway function and systemic inflammation in CF. Secondary aim was to compare alveolar NO and bronchial NO flux calculated by two different mathematical models, a linear and a nonlinear method. Thirty-five healthy and 45 CF children were recruited. FENO at 50 ml/sec (FENO(50)) and bronchial NO flux were lower in CF than controls, 9.5 (2.7-38.8) (median (range)) versus 12.4 (5.2-40.1) ppb, P = 0.029, and 391 (97-1772) versus 578 (123-1993) (pl/sec), P = 0.036, respectively. No difference in alveolar NO was shown. The nonlinear method resulted in lower alveolar NO and higher bronchial flux, than the linear method, but the result was closely correlated in both groups. LCI was higher in CF than controls, 8.4 (6.5-12.9) versus 5.9 (5.1-7.8), P < 0.001. FENO(50) was negatively correlated with LCI (r = -0.43; P = 0.003) and positively correlated with FEV(1) (r = 0.42, P = 0.004) in CF. Alveolar NO correlated negatively with inflammatory markers: orosomucoid (r = -0.42, P = 0.005), platelets (r = -0.50, P < 0.001) and white blood cell count (r = -0.48, P = 0.001). In conclusion, FENO(50) and bronchial NO flux are reduced in young CF subjects and low FENO(50) is associated with overall and small airway obstruction. NO parameters derived from the different models were closely related but the values differed slightly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146368     DOI: 10.1002/ppul.21137

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  11 in total

1.  Tidal lung recruitment and exhaled nitric oxide during coronary artery bypass grafting in patients with and without chronic obstructive pulmonary disease.

Authors:  Alysson R Carvalho; Fumito Ichinose; Ivany A Schettino; Dean Hess; Javier Rojas; Antonio Giannella-Neto; Arvind Agnihotri; Jennifer Walker; Thomas E MacGillivray; Marcos F Vidal Melo
Journal:  Lung       Date:  2011-09-28       Impact factor: 2.584

2.  Nitric Oxide-Releasing Cyclodextrins.

Authors:  Haibao Jin; Lei Yang; Mona Jasmine R Ahonen; Mark H Schoenfisch
Journal:  J Am Chem Soc       Date:  2018-10-16       Impact factor: 15.419

Review 3.  Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset.

Authors:  Geraint B Rogers; Lucas R Hoffman; Matt W Johnson; Nicole Mayer-Hamblett; Jürgen Schwarze; Mary P Carroll; Kenneth D Bruce
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

Review 4.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

Review 5.  The Consequences of Being in an Infectious Biofilm: Microenvironmental Conditions Governing Antibiotic Tolerance.

Authors:  Majken Sønderholm; Thomas Bjarnsholt; Maria Alhede; Mette Kolpen; Peter Ø Jensen; Michael Kühl; Kasper N Kragh
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

6.  Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic Treatment.

Authors:  Beatrice Hanusch; Folke Brinkmann; Sebene Mayorandan; Kristine Chobanyan-Jürgens; Anna Wiemers; Kathrin Jansen; Manfred Ballmann; Anjona Schmidt-Choudhury; Alexander Bollenbach; Nico Derichs; Dimitrios Tsikas; Thomas Lücke
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

Review 7.  NO donors and NO delivery methods for controlling biofilms in chronic lung infections.

Authors:  Yu-Ming Cai; Ying-Dan Zhang; Liang Yang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-03       Impact factor: 5.560

8.  Decreased exhaled nitric oxide levels in patients with mitochondrial disorders.

Authors:  Ricardo A Mosquera; Cheryl L Samuels; Tomika S Harris; Aravind Yadav; S Shahrukh Hashmi; Melissa S Knight; Mary Kay Koenig
Journal:  Open Respir Med J       Date:  2013-07-26

9.  Application of nitric oxide measurements in clinical conditions beyond asthma.

Authors:  Andrei Malinovschi; Dora Ludviksdottir; Ellen Tufvesson; Giovanni Rolla; Leif Bjermer; Kjell Alving; Zuzana Diamant
Journal:  Eur Clin Respir J       Date:  2015-08-17

10.  Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease.

Authors:  Kristijan Bogdanovski; Trisha Chau; Chevalia J Robinson; Sandra D MacDonald; Ann M Peterson; Christine M Mashek; Windy A Wallin; Mark Rimkus; Frederick Montgomery; Joas Lucas da Silva; Shashank Gupta; Abdi Ghaffari; Adrian M Zelazny; Kenneth N Olivier
Journal:  Access Microbiol       Date:  2020-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.